Fewer weeks of hormone therapy before radiation reduces side effects in intermediate risk PCa

(American Society for Radiation Oncology) A shorter course of androgen suppression therapy prior to radiation therapy, when compared to a longer course of androgen suppression therapy, yields favorable outcomes and fewer adverse effects for intermediate-risk prostate cancer patients, according to research presented today at the American Society for Radiation Oncology's 55th Annual Meeting.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news